Literature DB >> 18751374

EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.

Dongmin Dang1, Amha Atakilit, Daniel M Ramos.   

Abstract

The extracellular matrix metalloproteinase inducer (EMMPRIN), found on the surface of many tumor cells, stimulates the production of matrix metalloproteinases (MMPs) by both fibroblasts and the tumor cells themselves. To evaluate its possible role as a tumor promoter, we first overexpressed EMMPRIN, by retroviral transduction, into poorly invasive squamous cell carcinoma (SCC) cells. Secondly, we knocked down its expression using small interfering RNA (siRNA) in invasive SCC cells. The cell lines were then re-evaluated for migration on fibronectin (FN). Overexpression of EMMPRIN, promoted motility, whereas the siRNA decreased migration. The MMP expression by these variant SCC cell lines was also manipulated by EMMPRIN. The expression of MMP-2, -3, and -9 coincided with the expression of EMMPRIN. Cocultures of SCC/peritumor fibroblasts (PTF) were used to investigate tenascin-C (TN-C) matrix deposition. The cocultures overexpressing EMMPRIN, deposited several fold greater levels of TN-C compared to the control cocultures. In addition, the siRNA cocultures deposited minimal amounts of TN-C. In the presence of the broad spectrum MMP inhibitor, GM6001, TN-C deposition by the EMMPRIN overexpressing cocultures was suppressed. Thus EMMPRIN regulates migration, MMP production by SCC cells and deposition of the TN-C matrix.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751374

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.

Authors:  Susana Simões-Sousa; Sara Granja; Céline Pinheiro; Daniela Fernandes; Adhemar Longatto-Filho; Ana Carolina Laus; Cira Danielle Casado Alves; J M Suárez-Peñaranda; Mario Pérez-Sayáns; Andre Lopes Carvalho; Fernando C Schmitt; Abel García-García; Fatima Baltazar
Journal:  Cell Cycle       Date:  2016-05-27       Impact factor: 4.534

2.  Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.

Authors:  Hua-chuan Zheng; Wei Wang; Xiao-yan Xu; Pu Xia; Miao Yu; Toshiro Sugiyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

3.  EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.

Authors:  Géraldine Lescaille; Suzanne Menashi; Bénédicte Cavelier-Balloy; Farah Khayati; Cathy Quemener; Marie Pierre Podgorniak; Benyoussef Naïmi; Fabien Calvo; Céleste Lebbe; Samia Mourah
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

4.  Melittin inhibits the invasion of MCF-7 cells by downregulating CD147 and MMP-9 expression.

Authors:  Jianjun Wang; Fengyu Li; Jiang Tan; Xuewei Peng; Lili Sun; Ping Wang; Shengnan Jia; Qingmiao Yu; Hongliang Huo; Hongyan Zhao
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

Review 5.  The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview.

Authors:  Giovanni Barillari; Ombretta Melaiu; Marco Gargari; Silvia Pomella; Roberto Bei; Vincenzo Campanella
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

6.  Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasis.

Authors:  Zhiquan Huang; Ning Tan; Weijie Guo; Lili Wang; Haigang Li; Tianyu Zhang; Xiaojia Liu; Qin Xu; Jinsong Li; Zhongmin Guo
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

7.  The role of EMMPRIN expression in ovarian epithelial carcinomas.

Authors:  Yang Zhao; Shuo Chen; Wen-feng Gou; Zhe-feng Niu; Shuang Zhao; Li-jun Xiao; Yasuo Takano; Hua-chuan Zheng
Journal:  Cell Cycle       Date:  2013-08-08       Impact factor: 4.534

8.  Interaction of stellate cells with pancreatic carcinoma cells.

Authors:  Hansjörg Habisch; Shaoxia Zhou; Marco Siech; Max G Bachem
Journal:  Cancers (Basel)       Date:  2010-09-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.